Exagen Inc. (XGN) — 10-Q Filings

10-Q Filings (6)

• Exagen's Revenue Jumps, But Losses Widen Amid Higher Costs — Nov 4, 2025 Risk: high
  EXAGEN INC. reported a significant increase in revenue for the three months ended September 30, 2025, reaching $17.244 million, up from $12.507 million in the p
• EXAGEN's Q2 Loss Widens Amidst New Debt Financing — Jul 29, 2025 Risk: high
  EXAGEN INC. reported a net loss of $12.9 million for the three months ended June 30, 2025, a significant increase from the $10.5 million net loss in the prior-y
• Exagen Inc. Files Q1 2025 10-Q Report — May 5, 2025 Risk: medium
  Exagen Inc. filed its 10-Q for the period ending March 31, 2025. The filing covers financial information and operational updates for the first quarter of 2025.
• Exagen Inc. Files Q3 2024 10-Q Report — Nov 12, 2024 Risk: medium
  Exagen Inc. filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter and the first nine months of the fiscal year. Specific
• Exagen Inc. Files Q2 2024 10-Q Report — Aug 5, 2024 Risk: medium
  Exagen Inc. filed its 10-Q for the period ending June 30, 2024. The company, headquartered in Vista, CA, operates in the medical laboratories sector. This filin
• Exagen Inc. Files 10-Q for Period Ending March 31, 2024 — May 13, 2024 Risk: medium
  EXAGEN INC. (XGN) filed a Quarterly Report (10-Q) with the SEC on May 13, 2024. Exagen Inc. reported financial results for the quarter ended March 31, 2024. The

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX